home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

6.640 -0.150 (-2.21%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DiaMedica Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Earnings Preview: DiaMedica Therapeutics ↗

May 12, 2023

Via Benzinga

DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

May 08, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

April 11, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results

March 28, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics's Earnings Outlook ↗

March 27, 2023

Via Benzinga

DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023

March 20, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 13, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

March 06, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying ↗

December 02, 2022

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

November 09, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022

November 07, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference

October 31, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides Update on ReMEDy2 Trial

October 26, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday ↗

October 28, 2022

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

September 14, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference

September 06, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics: Q2 Earnings Insights ↗

August 10, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Via Benzinga

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results

August 10, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

DiaMedica Therapeutics Earnings Preview ↗

August 09, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

Via Benzinga

DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022

August 04, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022

August 01, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More ↗

July 22, 2022

U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Nasdaq Surges 250 Points; Crude Oil Rises Sharply ↗

July 07, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 07, 2022

Thursday's session saw 49 companies set new 52-week lows.

Via Benzinga

Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue ↗

July 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.

Via Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session ↗

July 07, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com